The company offers a diverse portfolio of products and services, including APIs, generics, branded generics, biosimilars and over-the-counter medications. With a history of scientific advancements and industry-first achievements, the company remains committed to investing in future business opportunities.

Shares of the company surged 7 per cent on the day. 

Sun pharma has showcased poor 5-year growth numbers